Proteomic Analysis of Plasminogen Receptors

纤溶酶原受体的蛋白质组学分析

基本信息

  • 批准号:
    7589725
  • 负责人:
  • 金额:
    $ 47.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-06 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The assembly of plasminogen and plasminogen activators on cell surfaces is a crucial control point for positive regulation of cell surface proteolytic activity necessary in both physiological and pathological processes requiring cell migration. The long-term goal of our laboratory is to understand the mechanisms by which plasminogen binding to cells is regulated, in order to function in physiological and pathological processes. This proposal is based on data demonstrating that up-regulation of plasminogen binding function occurs during differentiation of viable monocytes into viable macrophages. In preliminary studies, we identified three major candidate plasminogen receptors up-regulated in response to M-CSF that have not been recognized previously as plasminogen binding sites on monocytes. The objective of this application is to elucidate the role of M-CSF-up-regulated plasminogen receptors in monocyte/macrophage recruitment. The central hypothesis to be addressed is that plasminogen receptors are up-regulated during monocyte/macrophage maturation and facilitate recruitment of these cells in response to inflammatory stimuli, by promoting plasminogen activation and localizing the proteolytic activity of plasmin on the cell surface. To test this hypothesis we will I) identify the major pro- fibrinolytic plasminogen binding proteins on M-CSF-stimulated cells and quantify their expression during monocyte development in vivo and II) test the hypothesis that M-CSF-up-regulated plasminogen receptors promote plasminogen activation, extracellular matrix degradation and cell migration in vitro and in vivo. We expect that accomplishment of our specific aims will provide fundamental insights that will apply to the regulation of inflammation. Furthermore, because monocyte/macrophage recruitment and infiltration is a key feature of the atherosclerotic lesion, our results should apply to the understanding of atherosclerosis.
描述(由申请方提供):纤溶酶原和纤溶酶原激活剂在细胞表面上的组装是细胞表面蛋白水解活性正调控的关键控制点,这在需要细胞迁移的生理和病理过程中是必需的。我们实验室的长期目标是了解纤溶酶原与细胞结合的调节机制,以便在生理和病理过程中发挥作用。该提议是基于证明纤溶酶原结合功能的上调发生在活的单核细胞分化成活的巨噬细胞期间的数据。在初步研究中,我们确定了三个主要的候选人纤溶酶原受体上调响应M-CSF尚未被公认为以前的单核细胞上的纤溶酶原结合位点。本申请的目的是阐明M-CSF上调的纤溶酶原受体在单核细胞/巨噬细胞募集中的作用。要解决的中心假设是,纤溶酶原受体在单核细胞/巨噬细胞成熟过程中上调,并通过促进纤溶酶原活化和将纤溶酶的蛋白水解活性定位在细胞表面上,促进这些细胞响应炎症刺激的募集。为了检验这一假设,我们将I)鉴定M-CSF刺激的细胞上的主要促纤溶纤溶酶原结合蛋白,并在体内单核细胞发育期间定量其表达,和II)检验M-CSF上调的纤溶酶原受体在体外和体内促进纤溶酶原活化、细胞外基质降解和细胞迁移的假设。我们期望我们特定目标的实现将提供适用于炎症调节的基本见解。此外,由于单核细胞/巨噬细胞的募集和浸润是动脉粥样硬化病变的一个关键特征,我们的研究结果应适用于动脉粥样硬化的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lindsey A Miles其他文献

Lindsey A Miles的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lindsey A Miles', 18)}}的其他基金

Distinguishing plasminogen-dependent and plasminogen-independent roles of the plasminogen receptor, Plg-RKT
区分纤溶酶原受体 Plg-RKT 的纤溶酶原依赖性和纤溶酶原非依赖性作用
  • 批准号:
    10219891
  • 财政年份:
    2020
  • 资助金额:
    $ 47.38万
  • 项目类别:
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
新型纤溶酶原受体促进脂肪功能和代谢稳态
  • 批准号:
    9918949
  • 财政年份:
    2019
  • 资助金额:
    $ 47.38万
  • 项目类别:
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
新型纤溶酶原受体促进脂肪功能和代谢稳态
  • 批准号:
    10397036
  • 财政年份:
    2019
  • 资助金额:
    $ 47.38万
  • 项目类别:
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
新型纤溶酶原受体促进脂肪功能和代谢稳态
  • 批准号:
    9765020
  • 财政年份:
    2019
  • 资助金额:
    $ 47.38万
  • 项目类别:
2016 Plasminogen Activation and Extracellular Proteolysis Gordon Research Conference and Gordon-Kenan Research Seminar
2016年纤溶酶原激活与细胞外蛋白水解戈登研究会议暨戈登-凯南研究研讨会
  • 批准号:
    8983504
  • 财政年份:
    2015
  • 资助金额:
    $ 47.38万
  • 项目类别:
Proteomic Analysis of Plasminogen Receptors
纤溶酶原受体的蛋白质组学分析
  • 批准号:
    7815746
  • 财政年份:
    2009
  • 资助金额:
    $ 47.38万
  • 项目类别:
Regulation of cellular functions by the plasminogen receptor, Plg-RKT
纤溶酶原受体 Plg-RKT 对细胞功能的调节
  • 批准号:
    10366010
  • 财政年份:
    2007
  • 资助金额:
    $ 47.38万
  • 项目类别:
Regulation of plasminogen-dependent cell functions by the novel receptor, Plg-RKT
新型受体 Plg-RKT 调节纤溶酶原依赖性细胞功能
  • 批准号:
    8913335
  • 财政年份:
    2007
  • 资助金额:
    $ 47.38万
  • 项目类别:
Regulation of plasminogen-dependent cell functions by the novel receptor, Plg-RKT
新型受体 Plg-RKT 调节纤溶酶原依赖性细胞功能
  • 批准号:
    8245547
  • 财政年份:
    2007
  • 资助金额:
    $ 47.38万
  • 项目类别:
Regulation of plasminogen-dependent cell functions by the novel receptor, Plg-RKT
新型受体 Plg-RKT 调节纤溶酶原依赖性细胞功能
  • 批准号:
    8438378
  • 财政年份:
    2007
  • 资助金额:
    $ 47.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了